B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

PKN3

MOLECULAR TARGET

protein kinase N3

UniProt: Q6P5Z2NCBI Gene: 299413 compounds

PKN3 (protein kinase N3) is targeted by 3 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting PKN3

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1fasudil3.6638
2lestaurtinib3.0420
3hydroxyfasudil [Supplementary Concept]0.691

About PKN3 as a Drug Target

PKN3 (protein kinase N3) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 3 compounds with documented PKN3 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

PKN3 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.